This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Braverman N, Steel G, Obie C, et al (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nature Genetics 15: 369–376.
Brul S, Westerveld A, Strijland A, et al (1988) Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. J Clin Invest 81: 1710–1715.
Dodt G, Braverman N, Wong C, et al (1995) Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nature Genetics 9: 115–125.
McGuiness MC, Moser AB, Moser HW, Watkins PA (1990) Peroxisomal disorders: complementation analysis using beta-oxidation of very long chain fatty acids. Biochem Biophys Res Commun 172: 364–369.
Moser AB, Rasmussen M, Naidu S, et al (1995) Phentotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 127: 13–22.
Motley A, Hettema E, Distel B, Tabak H (1994) Differential protein import deficiencies in human peroxisome assembly disorders. J Cell Biol 125: 755–767.
Motley AM, Hettema EH, Hogenhout EM, et al (1997) Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nature Genetics 15: 377–380.
Poll-The B, Skjeldal OH, Stokke O, Poulos A, Demaugre F, Saudubray JM (1989) Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders. Hum Genet 81: 175–181.
Portsteffen H, Beyer A, Becker E, et al (1997) Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nature Genetics 17: 449–452.
Purdue PE, Zhang JW, Skoneczny M, Lazarow PB (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nature Genetics 15: 381–384.
Reuber BE, Germain-Lee E, Collins CS, et al (1997) Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nature Genetics 17: 445–448.
Roscher AA, Hoefler S, Hoefler G, et al (1989) Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis: a complementation study involving cell lines from 19 patients. Pediatr Res 26: 67–72.
Shimozawa N, Suzuki Y, Orii T, Moser A, Moser HW, Wanders RJ (1993) Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am J Hum Genet 52: 843–844.
Shimozawa N, Suzuki Y, Zhang Z, et al (1998) Peroxisome biogenesis disorders: identification of a new complementation group distinct from peroxisome-deficient CHO mutants and not complemented by human PEX 13. Biochem Biophys Res Commun 243: 368–371.
Yajima S, Suzuki T, Shimozawa N, et al. (1992) Complementation study of peroxisomedeficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet 88: 491–499.
Wanders RJ, Wiemer EA, Brul S, Schutgens RB, van den Bosch H, Tager JM (1989) Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy. J Inher Metab Dis 12 (supplement 2): 301–304.
Wanders RJA, Schutgens RBH, Barth PG (1995) Peroxisomal disorders: a review. J Neuropathol Exp Neurol 54: 726–739.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wanders, R.J.A., Mooijer, P.A.W., Dekker, C. et al. Disorders of peroxisome biogenesis: Complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency). J Inherit Metab Dis 22, 314–318 (1999). https://doi.org/10.1023/A:1005504104541
Issue Date:
DOI: https://doi.org/10.1023/A:1005504104541